NCT07455617 2026-04-06
Study of ABO2102 in KRAS-Mutated Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
Phase 1 Recruiting
Suzhou Abogen Biosciences Co., Ltd.
ImmVirx Pty Ltd
Innovent Biologics (Suzhou) Co. Ltd.
Second Xiangya Hospital of Central South University
Sichuan University